Answers are grounded in this paper and cite their sources.
Ricin, one of type II ribosomal inactivating proteins, inhibits protein biosynthesis by its RNA N-glycosidase activity. By yeast two-hybrid screening, the human BAT3 (HLA-B-associated transcript 3) was isolated as a ricin A-chain interacting protein. A canonical caspase-3 cleavage site, DEQD(1001) was found at the C-terminal region of BAT3. Ricin induced the apoptosis by activating caspase-3 and leading to the cleavage of BAT3 at 4 h after treatment while DNA laddering at 24 h. The cleavage is completely inhibited by zDEVD-fmk, a caspase-3 specific inhibitor. In addition, cleavage of BAT3 is blocked in caspase-3-deficient MCF-7 cells, indicating that BAT3 is a novel caspase-3 substrate. Evidence indicates that caspase-3 activated by ricin acts on BAT3 at the caspase cleavage site, DEQD(1001) to release a C-terminal fragment designated CTF-131. The CTF-131 induces phosphatidylserine exposure, cell rounding, and chromatin condensation as ricin does. Moreover, silencing expression of endogenous BAT3 concomitantly suppresses ricin-induced apoptosis. Together, our results suggest a model that ricin triggers morphological changes of apoptosis by caspase-3-mediated proteolytic activation of BAT3.
No takes yet. Share an insight, caveat, or question.
Wu et al. (2004) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: